Cargando…

Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis

BACKGROUND: Esophageal cancer is associated with synchronous or metachronous cancer at other primary sites. However, few studies have evaluated the second malignancies after the treatment of esophageal cancer. The present study aimed to clarify the frequency of and risk factors for the second malign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitani, Seiichiro, Kadowaki, Shigenori, Oze, Isao, Masuishi, Toshiki, Narita, Yukiya, Bando, Hideaki, Oonishi, Sachiyo, Hirayama, Yutaka, Tanaka, Tsutomu, Tajika, Masahiro, Koide, Yutaro, Kodaira, Takeshi, Abe, Tetsuya, Muro, Kei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943156/ https://www.ncbi.nlm.nih.gov/pubmed/31730285 http://dx.doi.org/10.1002/cam4.2688

Ejemplares similares

The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation
por: Mitani, Seiichiro, et al.
Publicado: (2019)

A Prospective Trial Evaluating the Safety of a Shortened Infusion of Ramucirumab in Patients with Gastrointestinal Cancer
por: Hashimoto, Naoya, et al.
Publicado: (2018)

Successful Treatment of Cardiac Angiosarcoma Associated with Disseminated Intravascular Coagulation with Nab-Paclitaxel: A Case Report and Review of the Literature
por: Honda, Kazunori, et al.
Publicado: (2017)

Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer
por: Honda, Kazunori, et al.
Publicado: (2019)

Combination of Oxaliplatin and 5-Fluorouracil/Leucovorin for Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Standard Therapies
por: Mitani, Seiichiro, et al.
Publicado: (2019)

A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study
por: Honda, Kazunori, et al.
Publicado: (2018)

Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy: A case series and review of the literature
por: Mitani, Seiichiro, et al.
Publicado: (2017)

Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancer
por: Taniguchi, Hiroya, et al.
Publicado: (2021)

Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center
por: Ando, Masashi, et al.
Publicado: (2023)

A novel method of endoscopic submucosal dissection using a threaded clip for a lesion of the greater curvature of the gastric body
por: Yamada, Keisaku, et al.
Publicado: (2023)

Pseudocirrhosis in Gastric Cancer with Diffuse Liver Metastases after a Dramatic Response to Chemotherapy
por: Mitani, Seiichiro, et al.
Publicado: (2016)

Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study
por: Taniguchi, Hiroya, et al.
Publicado: (2023)

Radial incision and cutting under gel immersion as a useful method for refractory anastomotic stricture
por: Yamada, Keisaku, et al.
Publicado: (2022)

Trends in the incidence of head and neck cancer by subsite between 1993 and 2015 in Japan
por: Kawakita, Daisuke, et al.
Publicado: (2022)

Ursodeoxycholic acid and bezafibrate were useful for steroid-refractory, immune-related hepatitis: a case report
por: Onishi, Sachiyo, et al.
Publicado: (2020)

Revisit of an unanswered question by pooled analysis of eight cohort studies in Japan: Does cigarette smoking and alcohol drinking have interaction for the risk of esophageal cancer?
por: Oze, Isao, et al.
Publicado: (2019)

Impact of tumour growth rate during preceding treatment on tumour response to regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer
por: Masuishi, Toshiki, et al.
Publicado: (2019)

Prognostic Significance of Sarcopenia in Patients with Unresectable Advanced Esophageal Cancer
por: Onishi, Sachiyo, et al.
Publicado: (2019)

Updated Immunotherapy for Gastric Cancer
por: Narita, Yukiya, et al.
Publicado: (2023)

Eligibility for cardiovascular risk screening among different ethnic groups: The HELIUS study
por: Perini, Wilco, et al.
Publicado: (2019)

Social participation and coronary heart disease risk in a large prospective study of UK women
por: Floud, Sarah, et al.
Publicado: (2015)

Hemodynamic Gain Index Is Associated With Cardiovascular Mortality and Improves Risk Prediction: A PROSPECTIVE COHORT STUDY
por: Laukkanen, Jari A., et al.
Publicado: (2023)

Impact of tumor growth rate during preceding treatment on tumor response to nivolumab or irinotecan in advanced gastric cancer
por: Kato, K., et al.
Publicado: (2021)

Association between serum erythropoietin levels and renal reversibility in patients with renal impairment from multiple myeloma
por: Kobayashi, Hiroki, et al.
Publicado: (2020)

A Rare Case of Ampullary Goblet Cell Carcinoid
por: Shibuya, Hitoshi, et al.
Publicado: (2018)

STATIN USE AT TIME OF RESPIRATORY VIRAL INFECTION IN PATIENTS WITH PRIOR HISTORY OF CARDIOVASCULAR DISEASE AND RISK OF SUBSEQUENT CARDIOVASCULAR EVENTS
por: Knight, Stacey, et al.
Publicado: (2015)

Risk Prediction for Gastric Cancer Using GWAS-Identifie Polymorphisms, Helicobacter pylori Infection and Lifestyle-Related Risk Factors in a Japanese Population
por: Ishikura, Naoyo, et al.
Publicado: (2021)

A population‐based study of 92 clinically recognized risk factors for heart failure: co‐occurrence, prognosis and preventive potential
por: Banerjee, Amitava, et al.
Publicado: (2022)

Incidence and relative risk of metachronous second primary cancers for 16 cancer sites, Osaka, Japan, 2000–2015: Population‐based analysis
por: Odani, Satomi, et al.
Publicado: (2021)

A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer
por: Yamaguchi, Kazuhisa, et al.
Publicado: (2015)

Cardiorespiratory Optimal Point Is a Submaximal Exercise Test Variable and a Predictor of Mortality Risk: THE BALL STATE ADULT FITNESS LONGITUDINAL LIFESTYLE STUDY (BALL ST)
por: Peterman, James E., et al.
Publicado: (2022)

Observational study of first-line chemotherapy including cetuximab in patients with metastatic colorectal cancer: CORAL trial
por: Muro, Kei, et al.
Publicado: (2019)

Long-term outcomes of metachronous neoplasms in the ileal pouch and rectum after surgical treatment in patients with familial adenomatous polyposis
por: Tajika, Masahiro, et al.
Publicado: (2019)

Advocacy to reduce the risk of myopia
por: Fricke, Tim, et al.
Publicado: (2019)

Value of incorporating newly identified risk factors into risk prediction for chemotherapy‐induced febrile neutropenia
por: Li, Yanli, et al.
Publicado: (2018)

Dramatic Response in a Patient with Metastatic Gastric Cancer Using Trifluridine/Tipiracil after Rapid Disease Progression while on Nivolumab
por: Nozawa, Kazuki, et al.
Publicado: (2020)

Decreased liver B vitamin-related enzymes as a metabolic hallmark of cancer cachexia
por: Kojima, Yasushi, et al.
Publicado: (2023)

Breast Cancer Screening for High-Risk Patients of Different Ages and Risk - Which Modality Is Most Effective?
por: Wellings, Elizabeth, et al.
Publicado: (2016)

Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer
por: Kawai, Sadayuki, et al.
Publicado: (2020)

Risk of cancer in patients with fecal incontinence
por: Adelborg, Kasper, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nbcbocri60bbd1g81ob7n41heq